EconoTicker

Teva (TEVA) reported Q1 2025 earnings of $0.52 per share, beating expectations of $0.48. However, revenue came in slightly below forecasts at $3.9 billion versus the projected $3.98 billion. With total assets at $19.42 billion, the company remains focused on stabilizing its generic drug portfolio and expanding its specialty pipeline.

Coca-Cola Femsa (KOF) reported Q1 2025 earnings of $26.30 per share, topping the expected $25.63. Revenue also slightly exceeded forecasts at $69.97 billion, compared to the projected $69.69 billion. With total assets of $19.52 billion, the company continues to benefit from resilient beverage demand across Latin America.

Uber Technologies (UBER) reported Q1 2025 earnings of $0.83 per share, significantly above the expected $0.51. However, revenue came in just below estimates at $11.53 billion versus the forecasted $11.62 billion. With total assets at $175.16 billion, Uber continues to benefit from strong ride-hailing demand, though delivery and freight segments showed signs of moderation.

On May 7, 2025, the U.S. Federal Reserve maintained its benchmark interest rate at 4.25%–4.50%, marking the third consecutive meeting without a change. Fed Chair Jerome Powell emphasized a cautious approach, citing heightened risks of both inflation and unemployment, particularly due to recent tariff increases. Despite a 0.3% GDP contraction in Q1, the labor market remains robust, with April nonfarm payrolls exceeding expectations. Powell indicated that while the economy is solid, the Fed prefers to await clearer economic signals before adjusting rates. Markets now anticipate a potential rate cut in July, contingent on evolving economic conditions

Uber Technologies (UBER) reported Q1 2025 earnings of $0.83 per share, significantly above the expected $0.51. However, revenue came in just below estimates at $11.53 billion versus the forecasted $11.62 billion. With total assets at $175.16 billion, Uber continues to benefit from strong ride-hailing demand, though delivery and freight segments showed signs of moderation.

Walt Disney (DIS) reported Q1 2025 earnings of $1.45 per share, surpassing the expected $1.21. Revenue also came in stronger than expected at $23.62 billion versus the forecasted $23.13 billion. With total assets at $183.91 billion, Disney continues to benefit from robust theme park performance and steady streaming growth.

Marriott International (MAR) reported Q1 2025 earnings of $2.32 per share, exceeding the expected $2.26. Revenue came in at $6.26 billion, slightly above the forecasted $6.2 billion. With total assets of $69.38 billion, Marriott continues to benefit from steady global travel demand and strong occupancy rates across key markets.

Ferrari (RACE) reported Q1 2025 earnings of $2.30 per share, beating the expected $2.25. Revenue also came in slightly higher at $1.79 billion versus the forecasted $1.77 billion. With total assets reaching $84.29 billion, Ferrari continues to demonstrate strong demand and pricing power in the luxury automotive market.

Advanced Micro Devices (AMD) reported Q1 2025 earnings of $0.96 per share, narrowly beating the expected $0.95. Revenue also came in above forecasts at $7.44 billion versus $7.11 billion expected. With total assets at $159.4 billion, AMD continues to benefit from strong demand in AI, data centers, and high-performance computing.

The latest Redbook Retail Sales (YoY) reading rose to 6.9%, up from 6.1% in the previous week. This stronger pace of annual growth suggests resilient consumer spending in early Q2, potentially supporting broader retail sector momentum despite mixed macroeconomic signals.

The U.S. trade deficit expanded to $140.5 billion in March, widening significantly from $123.2 billion in February and missing the forecast of $136.8 billion. While exports held steady at $278.5 billion, imports surged to $419.0 billion, reflecting increased demand for foreign goods amid resilient consumer spending. The wider gap may weigh on Q1 GDP revisions and adds pressure to ongoing tariff-related trade dynamics.

BioNTech (BNTX) posted a Q1 2025 loss of $1.73 per share, outperforming expectations of a $2.00 loss. However, revenue came in below estimates at $182.8 million versus the projected $204.08 million. With total assets at $24.26 billion, the biotech firm continues to navigate post-COVID demand normalization while investing in its oncology pipeline.